Perimeter Medical Imaging AI, Inc. (PINK.V) Stock Analysis
Perimeter offers a high-risk, AI-powered medtech option on real-time cancer surgery margin assessment, with FDA validation and a recurring revenue model offset by reimbursement uncertainty, commercialization risk, and heavy dilution.
Overview
Perimeter Medical Imaging AI is a commercial-stage medtech company targeting a major unmet need in cancer surgery: reducing repeat operations caused by positive margins. Its Claire OCT system, FDA PMA-approved in March 2026, combines ultra-high-resolution intraoperative imaging with AI-assisted cancer detection. The business has shifted from capital equipment sales to recurring revenue from leases, consumable cassettes, and service plans. The opportunity is substantial, but execution depends on converting hospital leads, scaling placements, navigating reimbursement, and managing dilution.